- Home
- TIPT vs IMNM Comparison
TIPT vs IMNM Comparison
Compare TIPT & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIPT
- IMNM
- Stock Information
- Founded
- TIPT 2007
- IMNM 2006
- Country
- TIPT United States
- IMNM United States
- Employees
- TIPT N/A
- IMNM N/A
- Industry
- TIPT Property-Casualty Insurers
- IMNM Medicinal Chemicals and Botanical Products
- Sector
- TIPT Finance
- IMNM Health Care
- Exchange
- TIPT Nasdaq
- IMNM Nasdaq
- Market Cap
- TIPT 856.4M
- IMNM 748.3M
- IPO Year
- TIPT 2007
- IMNM 2020
- Fundamental
- Price
- TIPT $21.54
- IMNM $10.87
- Analyst Decision
- TIPT
- IMNM Strong Buy
- Analyst Count
- TIPT 0
- IMNM 5
- Target Price
- TIPT N/A
- IMNM $26.40
- AVG Volume (30 Days)
- TIPT 225.6K
- IMNM 1.2M
- Earning Date
- TIPT 08-04-2025
- IMNM 08-11-2025
- Dividend Yield
- TIPT 1.11%
- IMNM N/A
- EPS Growth
- TIPT 107.58
- IMNM N/A
- EPS
- TIPT 1.20
- IMNM N/A
- Revenue
- TIPT $2,042,059,000.00
- IMNM $10,938,000.00
- Revenue This Year
- TIPT N/A
- IMNM N/A
- Revenue Next Year
- TIPT N/A
- IMNM $259.34
- P/E Ratio
- TIPT $17.89
- IMNM N/A
- Revenue Growth
- TIPT 15.66
- IMNM N/A
- 52 Week Low
- TIPT $17.07
- IMNM $5.15
- 52 Week High
- TIPT $26.90
- IMNM $16.81
- Technical
- Relative Strength Index (RSI)
- TIPT 46.24
- IMNM 64.63
- Support Level
- TIPT $20.86
- IMNM $7.96
- Resistance Level
- TIPT $21.75
- IMNM $11.68
- Average True Range (ATR)
- TIPT 0.80
- IMNM 0.60
- MACD
- TIPT -0.00
- IMNM 0.22
- Stochastic Oscillator
- TIPT 32.60
- IMNM 78.23
About TIPT Tiptree Inc.
Tiptree Inc is a United States-based company that provides specialty insurance products and related services. It has two reportable segments: Insurance and Mortgage. The company generates the majority of its revenue from the Insurance Segment, which is engaged in designing, marketing, and underwriting specialty property and casualty insurance products incorporating value-added coverages and services for select target markets or niches. The Mortgage segment originates loans for sale to institutional investors, including GSEs and FHA/VA, and services loans on behalf of Fannie Mae, Freddie Mac, and Ginnie Mae.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.